Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2001;85:177-179; doi:10.1136/adc.85.3.177
Copyright © 2001 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Arch Dis Child 2001;85:177-179 ( September )
Current topic

Medicines for children---the last century and the next

T Stephenson

Academic Division of Child Health, School of Human Development, University Hospital, Nottingham NG7 2UH, UK

Correspondence to: Prof. Stephenson Terence.Stephenson@nottingham.ac.uk

Accepted 30 May 2001

The first 150 words of the full text of this article appear below.

    Introduction

Paediatricians, neonatal/paediatric pharmacists, and chief executives of hospital trusts recently received a position statement on the use of unlicensed medicines, produced by the Joint Standing Committee on Medicines of the Royal College of Paediatrics and Child Health (RCPCH) and the Neonatal and Paediatric Pharmacy Group (NPPG).


    The licensing of medicines

Before a pharmaceutical company can promote a drug, it must obtain a licence.1 Following the 1960s thalidomide disaster,2 "legislation was introduced to ensure that no new drug could be marketed until independent experts were agreed that it had been adequately tested and was safe".2 The process differs between countries but the principles are that the company must show the safety, quality, and efficacy of the drug when given in the dose and for the disease and age group recommended in the Summary of Product Characteristics (SPC). Drugs are increasingly licensed on a European Union wide basis. In the UK, doctors can legally prescribe drugs . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Permanand, G., Mossialos, E., McKee, M. (2007). The EU's new paediatric medicines legislation: serving children's needs?. Arch. Dis. Child. 92: 808-811 [Abstract] [Full Text]  
  • Stephenson, T, Budge, H (2006). The future of neonatal therapeutic trials.. Arch. Dis. Child. Fetal Neonatal Ed. 91: F305-F307 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs